Using exosomes from dendritic cells to treat inflammatory bone loss and oral infections
DC exosome therapy to resolve inflammatory bone loss and oral infection
This study is exploring a new way to treat gum disease by using tiny particles called exosomes to help calm inflammation and protect your bones, and it's designed for people with periodontitis who want to learn about innovative treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-11074646 on NIH RePORTER |
What this research studies
This research investigates a new treatment approach for periodontitis, a disease that causes bone loss and increases the risk of other serious health issues. The study focuses on using exosomes, which are tiny particles released by dendritic cells, to reprogram immune responses in the gums. By injecting these exosomes directly into the affected areas, the goal is to reduce inflammation and prevent further bone loss. The research will involve both laboratory studies and experiments in mice to understand how these exosomes work and their potential effects in humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from periodontitis or related inflammatory conditions affecting the gums and bone.
Not a fit: Patients without periodontitis or those with other unrelated dental issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that effectively treat periodontitis and prevent associated health complications.
How similar studies have performed: While this approach is novel in the context of treating periodontitis, similar strategies using exosomes in other immune-mediated diseases have shown promising results.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Elsayed, Ranya — Augusta University
- Study coordinator: Elsayed, Ranya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.